[1]
2025. Design and Synthesis of Novel Triazole-Isofroxadin Molecules: Docking Studies Against Inflammatory and Tuberculosis Targets. Indian Journal of Chemistry (IJC). 64, 3 (Mar. 2025), 285–290. DOI:https://doi.org/10.56042/ijc.v64i3.16320.